Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KLRS
2751
Kalaris Therapeutics
KLRS
$97.1M
| $518K | ﹤0.01% |
33,129
+18,619
| +128% | +$734K |
|
|
TVRD
2752
Tvardi Therapeutics
TVRD
$23.7M
| $518K | ﹤0.01% |
19,362
+10,698
| +123% | +$443K |
|
2753
Ohio Valley Banc Corp
OVBC
$210M
| $517K | ﹤0.01% |
22,475
-100
| -0.4% | -$2.37K |
|
2754
Lesaka Technologies
LSAK
$407M
| $516K | ﹤0.01% |
159,276
+11,876
| +8% | +$46.3K |
|
2755
Mid Penn Bancorp
MPB
$974M
| $516K | ﹤0.01% |
+21,269
| New | +$453K |
|
2756
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$399M
| $516K | ﹤0.01% |
6,100
-7,000
| -53% | -$607K |
|
2757
SCYNEXIS
SCYX
$51.5M
| $515K | ﹤0.01% |
28,868
+22,088
| +326% | +$324K |
|
2758
Simulations Plus
SLP
$371M
| $515K | ﹤0.01% |
+11,500
| New | +$456K |
|
2759
Santander
BSBR
$43.2B
| $514K | ﹤0.01% |
78,500
+68,000
| +648% | +$401K |
|
2760
Dianthus Therapeutics
DNTH
$6.49B
| $513K | ﹤0.01% |
49,306
+14,090
| +40% | +$156K |
|
|
PARAA
2761
DELISTED
Paramount Global Class A
PARAA
| $513K | ﹤0.01% |
26,103
+2,100
| +9% | +$35.9K |
|
2762
Applied Optoelectronics
AAOI
$12.7B
| $510K | ﹤0.01% |
26,400
-841,179
| -97% | -$11M |
|
|
DNMR
2763
DELISTED
Danimer Scientific, Inc.
DNMR
| $509K | ﹤0.01% |
+12,468
| New | +$678K |
|
2764
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
| $508K | ﹤0.01% |
+20,500
| New | +$493K |
|
|
HYPD
2765
Hyperion DeFi Inc
HYPD
$41.2M
| $507K | ﹤0.01% |
3,048
-2,329
| -43% | -$275K |
|
2766
iShares US Infrastructure ETF
IFRA
$4.66B
| $507K | ﹤0.01% |
12,600
-3,700
| -23% | -$138K |
|
2767
Value Line
VALU
$353M
| $507K | ﹤0.01% |
10,400
+100
| +1% | +$4.26K |
|
|
OPOF
2768
DELISTED
Old Point Financial
OPOF
| $506K | ﹤0.01% |
28,235
+1,600
| +6% | +$27K |
|
2769
Appian
APPN
$2.54B
| $505K | ﹤0.01% |
+13,400
| New | +$524K |
|
2770
Asure Software
ASUR
$245M
| $505K | ﹤0.01% |
53,000
-15,600
| -23% | -$130K |
|
2771
Fidelity D&D Bancorp
FDBC
$324M
| $505K | ﹤0.01% |
8,700
| – | – |
|
2772
Avita Medical
RCEL
$243M
| $505K | ﹤0.01% |
36,800
-34,400
| -48% | -$394K |
|
2773
Telesat
TSAT
$771M
| $503K | ﹤0.01% |
48,182
+24,282
| +102% | +$272K |
|
|
TE
2774
T1 Energy
TE
$1.51B
| $503K | ﹤0.01% |
+269,200
| New | +$726K |
|
|
SLAI
2775
DELISTED
SOLAI Ltd ADS
SLAI
| $502K | ﹤0.01% |
+14,226
| New | +$350K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.